Jason Gotlib
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Hematology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Hematology Clinic 875 Blake Wilbur Dr Clinic C MC 5820 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 498-5030
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Hematology
- Hematology
Honors and Awards
- NIH K23 Mentored Patient-Oriented Research Career Development Award (#HL04409), National Institutes of Health (2001-2006)
- Hematology Division Faculty Teaching Award, Stanford Division of Hematology/Department of Medicine (2005, 2007, 2009)
- Charles Dorsey Armstrong Award for Excellence in Patient Care, Stanford Internal Medicine Residency Program (1998)
Professional Education
| Fellowship: | Stanford University School of Medicine CA (2003) |
| Residency: | Stanford University School of Medicine CA (1998) |
| Internship: | Stanford University School of Medicine CA (1996) |
| Medical Education: | Stanford University School of Medicine CA (1995) |
| B.A.: | Franklin & Marshall College, Biology; HAPOS (1990) |
| M.D.: | Stanford, Medicine (1995) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
My research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:
--Myelodysplastic syndromes (MDS)
--Chronic myelogenous leukemia (CML)
--Acute myelogenous leukemia (AML)
--Myeloproliferative disorders (MPDs) including:
Hypereosinophilic syndrome
Systemic mastocytosis
BCR-ABL-negative MPDs
Clinical Trials
- Not Recruiting To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
- Recruiting Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
- Recruiting An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
- Not Recruiting Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
- Recruiting S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Publications
- Accessory splenules in autoimmune hemolytic anemia. Am J Hematol. 2013; (2): 156
- Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2013; (10): 1285-92
- International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. Blood. 2013; (13): 2393-401
- DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups. Br J Haematol. 2012; (2): 182-90
- ICON: Eosinophil Disorders. World Allergy Organ J. 2012; (12): 174-181
- Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders. Semin Hematol. 2012; (2): 128-37
Help